精神分裂症中的REM睡眠:系统性审查和元分析
Dario Morra1, Giuseppe Barbato1
1Università degli Studi della Campania "Luigi Vanvitelli" - Department of Psychology, Viale Ellittico 31, Caserta, Italy.
Sleep medicine reviews
|July 24, 2025
概括
与健康人相比,精神分裂症患者表现出改变的快速眼动 (REM) 睡眠,减少REM时间和缩短REM延迟时间. 抗精神病治疗可以使一些REM睡眠特征正常化,但不能使REM密度正常化.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 睡眠医学 睡眠医学
背景情况:
- 精神分裂症是一种复杂的精神障碍,与各种神经生物学异常有关.
- 睡眠障碍,特别是快速眼动 (REM) 睡眠,在精神分裂症中经常被报告.
- 了解REM睡眠变化可能会为精神分裂症的病理生理学和治疗提供洞察力.
研究的目的:
- 系统地审查和对精神分裂症患者的REM睡眠参数进行元分析.
- 为了比较精神分裂症患者的REM睡眠发现 (无药,无药,接受治疗) 与健康对照和抑郁患者.
- 为了研究抗精神病治疗对REM睡眠的影响.
主要方法:
- 从1955年到2025年发表的研究的系统审查和元分析.
- 包括92项病例对照研究,涉及1845名精神分裂症患者,1269名健康对照和262名抑郁症患者.
- 使用随机效应模型分析REM睡眠参数,包括REM时间,百分比,延迟和密度.
主要成果:
- 与健康对照组相比,精神分裂症患者的REM时间缩短,REM延迟缩短.
- 在未服用药物和接受治疗的精神分裂症患者中,REM密度增加.
- 在精神分裂症患者和健康对照人群之间没有观察到REM百分比的显著差异.
- 精神分裂症患者的REM延迟减少类似于抑郁症患者的REM延迟.
- 抗精神病治疗似乎能使REM时间和REM延迟正常化,但不能使REM密度正常化.
结论:
- 精神分裂症的特点是特定的REM睡眠异常,包括减少REM时间和延迟,增加REM密度.
- 精神分裂症的REM睡眠变化与抑郁症的REM睡眠变化有相似之处,特别是在REM延迟方面.
- 抗精神病药物可能部分使REM睡眠正常化,但REM密度表明不同的潜在机制可能独立于REM发生调节.
相关概念视频
REM Sleep Behavior Disorder
413
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
413
Substance Use Disorders Affecting Sleep
217
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
217
Sleep-Wake Cycles
1.6K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.6K
Management of Insomnia
323
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
323
Sedatives and Hypnotics Drugs: Miscellaneous Agents
243
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
243
Narcolepsy
198
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
198


